Inovio Pharmaceuticals
INO
INO
106 hedge funds and large institutions have $160M invested in Inovio Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
10% less funds holding
Funds holding: 118 → 106 (-12)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
Holders
106
Holding in Top 10
–
Calls
$481K
Puts
$398K
Top Buyers
| 1 | +$4.13M | |
| 2 | +$3.06M | |
| 3 | +$2.77M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.2M |
| 5 |
Renaissance Technologies
New York
|
+$741K |
Top Sellers
| 1 | -$928K | |
| 2 | -$696K | |
| 3 | -$593K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$526K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$379K |